Morning Market Losers
March 25, 2015 at 09:46 AM EDT
Lpath Inc. (NASDAQ: LPTN) shares fell 25.08% to $2.45 after the company reported Phase 2a study results for ASONEP in renal cell ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.